Abstract-Weight gain may increase blood pressure. Weight loss may reduce this. Reviews have considered the long-term effects of weight loss but are related mainly to more obese participants often on obesity medication and/or undergoing obesity surgery. This systematic review, based on lifestyle interventions for adults (18 to 65 years) with mean baseline BMI of Ͻ35 kg/m 2 , links weight change to blood pressure difference. A systematic review of studies reporting weight differences and blood pressure outcomes, published between 1990 and 2008 with follow-up of Ն2 years identified 8 clinical trials or controlled before and after studies (represented by 9 articles) and 8 cohort studies. Differences ranged from Ϫ11 to ϩ4kg for weight, Ϫ7 to ϩ2.2 mm Hg for diastolic blood pressure and Ϫ13 to ϩ6.1 mm Hg for systolic blood pressure. For this population group, no quantifiable relationship between weight and diastolic blood pressure difference was found, possibly because of small weight losses, differing weight status responses, or because pharmacologically controlled hypertension masked weight loss influences. Systolic differences were in line with previous reviews of 1 kg:1 mm Hg relationship, but only for follow-up periods of 2 to 3 years, possibly reflecting the fact that regardless of maintained weight loss, blood pressure often reverts back to higher levels. Lifestyle interventions for weight and blood pressure are limited in this target group, and there has been no exploration of successful intervention components. An individual patient data analysis may uncover baseline and medication effects, explore differences between weight groups, and may identify successful components. Such an analysis would enable effective development of preventative interventions for both hypertension and obesity. (Hypertension. 2009;54:00-00.) Key Words: lifestyle Ⅲ obesity prevention Ⅲ weight loss Ⅲ blood pressure H ypertension is an important risk factor for cardiovascular morbidity and mortality. 1,2 In adults, hypertension often rises with increasing body weight. 3 Intervention studies and reviews have reported blood pressure reductions associated with weight loss, particularly in the short-term. 4 -6 A recent review of long-term effects of weight loss on hypertension in overweight or obese subjects, excluding surgical weight loss interventions, concluded that blood pressure reduction was about half that found in short-term trials. 7 A leading aim of contemporary public health policy is to reduce levels of obesity, 8 although how to achieve this, or how effective population-level interventions to reduce obesity would be in reducing blood pressure, is still not evident. The aim of this research was to systematically review evidence linking long-term weight and lifestyle changes to blood pressure changes for those with a body mass index (BMI) of Յ35kg/m 2 .
H ypertension is an important risk factor for cardiovascular morbidity and mortality. 1, 2 In adults, hypertension often rises with increasing body weight. 3 Intervention studies and reviews have reported blood pressure reductions associated with weight loss, particularly in the short-term. 4 -6 A recent review of long-term effects of weight loss on hypertension in overweight or obese subjects, excluding surgical weight loss interventions, concluded that blood pressure reduction was about half that found in short-term trials. 7 A leading aim of contemporary public health policy is to reduce levels of obesity, 8 although how to achieve this, or how effective population-level interventions to reduce obesity would be in reducing blood pressure, is still not evident. The aim of this research was to systematically review evidence linking long-term weight and lifestyle changes to blood pressure changes for those with a body mass index (BMI) of Յ35kg/m 2 .
Methods
This review considers longitudinal data rather than "betweentreatment" data linking weight differences with blood pressure differences. Consequently, differences recorded for weight and blood pressure from clinical trials (CTs) (including randomized control trials), controlled before and after studies (CBAs), and cohort studies (including interrupted time series) between 1990 and 2008 were considered. Two systematic literature searches (part of a National Prevention Research Initiative-funded economic evaluation of obesity prevention for UK adults) were conducted. The first identified CTs and CBAs with lifestyle interventions to prevent weight gain. The second identified similar interventions in cohorts as well as studies without formal interventions but where weight loss/prevention was intentional and lifestyle based.
The searches used MeSH terms and text words for "Trials," "obesity," "overweight," "weight differences" appropriately combined. The first search, for CTs and CABs from 1990 onwards, was based on key reports, systematic reviews, and primary studies indexed in Medline, Embase, PsycINFO, CINAHL, The Evidence Based Medicine Reviews Collection, CAB Nutrition Abstracts and Reviews, along with hand searching of International Journal of Obesity and Obesity Research. The last date of this search was October 2007 (full details available from the authors). Studies relevant to longitudinal measures in both weight and health outcomes were considered in this review. These included lifestyle intervention arms (even if the other arms were surgical or drug-based) provided the inclusion criteria were met. Thus, although some of these studies were CTs, for our analysis there were no "true" control groups. The search was extended up to April 2008 using the same search strategy ensuring that all relevant studies from this phase were identified. Medline, Embase, and CINAHL were also searched from 1990 to 2008 for cohort studies. Reference lists from relevant primary and review articles were investigated.
Criteria for inclusion were a Ն2-year follow-up for studies with either lifestyle interventions for weight loss (dietary, exercise, behavioral, or environmental) or where weight loss was intentional (including weight cycling) along with records of long-term differences in blood pressure for adult (18 to 65 years at recruitment) participants. Studies were excluded if participants had a mean baseline BMI Ͼ35kg/m 2 , or had eating disorders, were pregnant, or were severely mentally or physically handicapped. Although there were no language restrictions, studies with ethnic groups not relevant to a UK setting were excluded along with small studies (Ͻ50 participants per subgroup at recruitment or Ͻ20 at follow up).
Foreign language papers were assessed by team members competent in the relevant language, or translated by a third party before assessment. All titles/abstracts and full text papers were independently assessed against the inclusion criteria by 2 reviewers, with any disagreements being arbitrated by discussion or by a third reviewer.
Statistical Analysis
Blood pressure (BP) changes related to weight loss in the long term were considered longitudinally for significance. Ideally, differences between follow-up and baseline were required along with associated precision. When not provided, suitable imputed estimates were made for mean differences using the change between means at follow-up and baseline. Similarly, associated standard deviations (SDs) were estimated using SD Dif ϭ ͱSD F 2 ϩ SD B 2 , where suffixes Dif, F, and B represent difference, follow-up, and baseline, respectively. Theoretically, the difference variance would be Dif
where FB is the covariance between follow-up and baseline measures. 9 However, where only estimates of baseline and follow-up variances are known, the proposed estimate gives a conservative measure with no covariance assumptions.
BP differences (and percentage changes) were correlated with weight differences and other variables that potentially affect BP, namely mean age, follow-up time, sex mix, and baseline variables. Meta-regression models were constructed using weighted least squares (WLS) regression predicting BP differences. Using the standard error (SE) of the mean differences of either the diastolic or systolic mean differences, model weights were defined as 1/SE 2 . The generated regression coefficients SEs then required adjustment to determine coefficient significance. 10 Initially all subgroups were included. However, some subgroups represented different follow-up times, consequently models were also constructed separately for follow-up times of 2 to 3 years and 3ϩ years.
Results
We initially present lifestyle arms of CTs followed by cohort studies with lifestyle interventions, and finally those studies with no intervention but where weight loss was intentional.
The searches identified 4977 abstracts, from which 405 full text documents were assessed resulting in 54 potentially suitable papers. Several articles required extra information from authors. Only once sufficient information was obtained was final inclusion possible. Of those with extractable data, 17 articles recorded BP measures, where 9 related to 8 CT studies [11] [12] [13] [14] [15] [16] [17] [18] [19] and 8 were cohort studies with either lifestyle interventions or with intentional weight loss. 20 -27 Supplemental Tables S1 and S2 (please see http://hyper.ahajournals.org) give the basic characteristics of these CTs and cohort studies.
Studies had between 24 and 72 months follow-up with single or mixed gender groups. Most studies reported differences in weight and BP from baseline to follow-up. However, one weight cycling study reported on the risk of developing hypertension after 2 years, having classified participants into weight cycling groups based on the previous 2 years of intentional weight differences.
Longitudinal differences in weight and BP were tested for significance (Tables 1 and 2 ) using imputed mean differences and SDs when difference information was not available. One study provided difference data without precision, hence the average SD (from studies with SDs of differences) was used. Measures of precision were occasionally given as standard error of the mean (SEM) or as confidence intervals (CIs). These were converted into SDs for consistency. Similarly, differences reported as percentage change were converted to actual means and SDs. Studies providing only BMI were converted to estimate weight (kg) using UK tables 28 to represent European or U.S. heights 29 as appropriate.
Clinical Trials
Two of the 8 CTs were diet-based, whereas the rest had diet and physical activity components; most had clinical or academic settings. The follow-up periods were 2 to 4.5 years. Two articles reported on the same study after 27 months 14 and 51 months. 15 Although the main analysis for this review will be longitudinal, it is worth noting that of the 8 CTs, only 4 had "true" controls and even then only 1 specified their control to have "no dietary advice." Otherwise, the control groups were under "usual care" for participants who had coronary artery disease, 12 hypertension, 13 or diabetes mellitus. 18 This probably meant that they received diet/physical activity advice and maybe even relevant medication. Therefore, adjustment for available "control group BP change" would only be truly appropriate for 1 study. 11 The weight and BP differences are given in Table 1 . Average weight losses of 4 to 10 kg were observed for the meal replacement study, 14, 15 being largest for the "2 replacement meal" arm (Group B) at 27 months. Other significant average weight losses were approximately 3 kg. 12, 17, 18 A walking group 19 lost on average nearly 4 kg, although this was not significant, probably because of the large estimated SD. The largest and significant average drop in systolic blood pressure (SBP), 15 mm Hg, was reported by the meal replacement study. 14, 15 Other relevant SBP reductions were approximately 4 mm Hg. Reductions in diastolic blood pressure (DBP) of 3 to 5 mm Hg were reported by the hypertension trials, 11,13 the meal replacement trial 14, 15 (significance suffers from small sample sizes), and the Finnish diabetes prevention study. 18 Interestingly, results from the hypertension studies 11, 13 suggest better BP reductions using weight-reducing diets rather than sodium restriction.
Cohort Studies
Seven of the 8 included cohorts (Table 2) had dietary or behavioral interventions, with some incorporating exercise or combinations of regimes. Interventions were delivered in different settings, ranging from residential clinics to freeliving work places with varying follow-up periods of 2 to 6 years. In addition, the frequency and duration of contact for each intervention differed; the residential intervention 25 was an intense 4-week period, whereas others were monthly or even annual while approximately half of the intervention studies gave no description of contact. Some of the cohort subgroups were retrospectively decided on depending on the adequacy of the intervention implementation and/or of the success of the individual patients weight loss.
The study set within primary care, Basler et al, 20 resulted in an average weight loss of 4.9 kg with large reductions in BP (6.9 and 8.7 mm Hg for DBP and SBP, respectively). The largest average weight loss (7.8 kg) was reported by Welty et al, 26 with reductions of 4 and 3 mm Hg for DBP and SBD, respectively. The Malmö 21 study tested the feasibility of lifestyle change. Only the impaired glucose intolerance (IGT) subgroup had a sufficient sample size to be selected here. After 6 years this group had a small but significant average weight loss, achieved the largest significant average SBP reduction along with significant DBP reductions. Kauffmann et al, 22 although not presenting actual values, showed a positive correlation between weight loss and BP reduction. Other studies had inconsistent relationships between weight and BP differences. The Spanish workplace study 23 had another reference, 30 suggesting possible gender confounding.
The Field et al study 24 assessed repeated intentional weight losses in women with self-reported hypertension risk over 4 years. Participants retrospectively described as weight cyclers were "not appreciably more likely than non weight-cyclers to be diagnosed with hypertension."
The Figure shows mean differences, with 95% confidence intervals, for weight and BP. These data, combined using random effects models, demonstrate overall average differences of Ϫ2.8 kg (95% CI, Ϫ13.2, 7.5) for weight, Ϫ1.9 mm Hg for DBP (95% CI, Ϫ9.5, 5.6) and Ϫ2.9 mm Hg for SBP (95% CI, Ϫ9.2, 3.3). These nonsignificant differences have wide confidence intervals. Formal associations were further examined by meta-regression.
Regression Analysis
In total there were gϭ26 subgroups with information on weight and BP changes. Correlations of mean weight differences and percent weight changes between mean BP differences were similar. Hence, for easier interpretation, only mean weight differences were used to develop regression models. Comparing BP differences with other variables indicate high correlations between baseline and final BPs and hence are considered in the models. The reported models reflect all data and then are split into follow-up times of 2 to 3 years and 3ϩ years. In addition, sensitivity analysis was conducted to assess the impact of the Spanish workplace study, 23 given the gender confounding concern. This latter sensitivity analysis indicated little difference and has not been further reported. The final prediction models for BP differences are presented in Table 3 .
The best predictors of difference in DBP used baseline DBP along with weight difference as independent variables. Imputed SD values based on average of 15 subgroups where SDs of mean differences were given. ¶Sample size not presented. The 54-month follow-up sample size used as a conservative estimate (drop off increases with time). **Marginally significant. † †Diet group nϭ527 for DBP and SBP. ‡ ‡Diet Na group nϭ537 for DBP and SBP. PA indicates physical activity; Na, sodium; SD, standard deviation.
However, this may reflect pharmacological treatment of hypertension rather than any weight loss effect. The model based only on weight differences accounted for 3% of the overall variation, indicating little consistent variability between changes of weight and DBP.
Weight difference alone was the most informative for predicting SBP pressure difference, accounting for 30% of the mean difference in SBP given by: Mean systolic BP difference (mm Hg)ϭϪ0.981ϩ0.921 (mean weight difference [kg] ).
The SBP model differs when broken down into 2 to 3 year and Ͼ3 years follow-up subgroups. The 2-to 3-year follow-up model accounts for 49% of the variation with similar model coefficients. However, the model for the longer follow-up subgroups was no longer valid, accounting for little variation, suggesting the strength of relationship reduces with time (Table 3) .
Discussion
This review determined weight loss effects on BP at Ն2 years from studies with lifestyle interventions for weight loss (or with intentional weight loss recorded). The target population was set for those of normal weight up to BMI Յ35.
Considered overall, a 3-kg weight loss may reduce BP. The hypertension trials suggest that sodium-restricted diets even without weight loss are beneficial, but that weight loss from calorie control gave better BP reduction. Patients under chronic disease management, particularly those with diabetes, had better weight losses with consequent BP improvement.
Prediction of the impact of weight loss was not possible for DBP given its high dependency on baseline DBP, possibly reflecting the fact that high initial DBP would be medically treated. In comparison, prediction of SBP for this target group suggests that an individual with a 5 kg weight loss may expect on average a 5.6 mm Hg drop in SBP.
A review by Netter et al 4 suggests that, for every kilogram of weight lost, a 1-mm Hg reduction is possible for both DBP and SBP. The findings here are similar for SBP but less predictable for DBP. Less responsive changes in DBP were also reported in our previous review on obese populations for all interventions of 2 or more years follow-up times. 7, 31 Clearly there is substantial heterogeneity between the different studies. The impact of the actual lifestyle interven- † †DBP and SBP measured by same nurse using a standard protocol. ‡ ‡Differences DBP nϭ387 and SBP nϭ386. § §Differences DBP nϭ324 and SBP nϭ324. nϭ60 for SBP and DBP differences. DBP indicates diastolic blood pressure; SBP, systolic blood pressure; IGT, impaired glucose tolerance; CHD, coronary heart disease; BMI, body mass index; SD, standard deviation.
tions without "true" control groups is difficult to assess, given that BP tends to increase over time and ideally this would be adjusted for in the analysis.
The effect of medication is difficult to disentangle, especially for DBP. Even for studies with no reported hypertension medication there is no guarantee that physicians did not prescribe antihypertensives. The TOHP 13 study suggests that BP measurements would be censored after initiation of antihypertensive drug treatment. However, studies reported patients with reduced medication, and Basler 20 showed that the greater the weight loss the greater the reduction of medication. Conducting an individual patient data (IPD) analysis may be useful, encompassing weight and BP differences along with other patient variables including medication.
It has been shown that initial reductions of BP seen with weight loss may be short lived. Even when weight loss is partially maintained in the long-term, BP tends to revert back to initial levels. 19 The lack of predictability for studies of longer than 3 years for SBP differences seen in this review may reflect this, suggesting that although weight loss is important, other aspects of lifestyle difference (such as increased physical activity, or improved diet) may also be critical for hypertension, as suggested for other target groups in our previous review. 7 Two of the studies, although included descriptively, were not combined analytically. Kauffmann et al 22 suggested that BP improved with weight loss in their adherent group. Field et al 24 concluded that there were no adverse effects of weight Refer to Supplementary Tables S1 and S2 for specific details of each sub-group Random: Random Effect model (heterogeneity): PA: physical activity; Na: sodium restricted Figure. Forest plot of mean differences in weight and diastolic and systolic blood pressure at follow-up of at least 2 years. 
Perspectives
This review suggests that lifestyle interventions are effective in reducing SBP, although the evidence for DBP was less convincing in this target group of normal to obese participants. This is an important group for obesity treatment but almost more importantly for obesity prevention and hence needs further more detailed investigation. A better understanding of treatment and prevention might be possible using individual patient data analysis, particularly on studies whose primary objective was weight reduction. This would allow for more flexible subgroup analysis and adjustments for covariates and confounding factors and may facilitate evaluation of interventions by taking their differing components into account.
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